Integrated single-cell transcriptome analysis reveals heterogeneity of esophageal squamous cell carcinoma microenvironment

[1]  Yongjin P. Park.  Faculty Opinions recommendation of SCENIC: single-cell regulatory network inference and clustering. , 2021, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

[2]  J. Ajani.  Faculty Opinions recommendation of Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus: The Phase 2 KEYNOTE-180 Study. , 2020, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

[3]  S. Achilefu,et al.  Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer , 2020, Theranostics.

[4]  F. Jamali,et al.  Single dose pharmacokinetics and bioavailability of glucosamine in the rat. , 2002, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[5]  Steffi Oesterreich,et al.  Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer. , 2019, Immunity.

[6]  A. Ochiai,et al.  Relationship between the immune microenvironment of different locations in a primary tumour and clinical outcomes of oesophageal squamous cell carcinoma , 2019, British Journal of Cancer.

[7]  R. Bourgon,et al.  Single-cell RNA sequencing reveals stromal evolution into LRRC15+ myofibroblasts as a determinant of patient response to cancer immunotherapy. , 2019, Cancer discovery.

[8]  Xianwen Ren,et al.  Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma , 2019, Cell.

[9]  Mariella G. Filbin,et al.  Rapid Generation of Somatic Mouse Mosaics with Locus-Specific, Stably Integrated Transgenic Elements , 2019, Cell.

[10]  Shasha Liu,et al.  Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling , 2019, Journal of Immunotherapy for Cancer.

[11]  P. Robson,et al.  Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts. , 2019, Cancer discovery.

[12]  G. Freeman,et al.  Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy. , 2019, Immunity.

[13]  Virginia Savova,et al.  Single-Cell Transcriptomics of Human and Mouse Lung Cancers Reveals Conserved Myeloid Populations across Individuals and Species. , 2019, Immunity.

[14]  Chun Jimmie Ye,et al.  Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity , 2019, Cell.

[15]  Zhihua Liu,et al.  Multi-region sequencing unveils novel actionable targets and spatial heterogeneity in esophageal squamous cell carcinoma , 2019, Nature Communications.

[16]  Jae U. Jung,et al.  SERPINB1-mediated checkpoint of inflammatory caspase activation , 2019, Nature Immunology.

[17]  Sung-Bae Kim,et al.  Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus: The Phase 2 KEYNOTE-180 Study , 2019, JAMA oncology.

[18]  F. Brunicardi,et al.  Single-cell RNA sequencing reveals diverse intratumoral heterogeneities and gene signatures of two types of esophageal cancers. , 2018, Cancer letters.

[19]  Kerstin B. Meyer,et al.  Single-cell reconstruction of the early maternal–fetal interface in humans , 2018, Nature.

[20]  Christoph Hafemeister,et al.  Comprehensive integration of single cell data , 2018, bioRxiv.

[21]  Paul J. Hoover,et al.  Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma , 2018, Cell.

[22]  Leland McInnes,et al.  UMAP: Uniform Manifold Approximation and Projection , 2018, J. Open Source Softw..

[23]  Ambrose J. Carr,et al.  Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment , 2018, Cell.

[24]  P. Carmeliet,et al.  Phenotype molding of stromal cells in the lung tumor microenvironment , 2018, Nature Medicine.

[25]  Jonathan Scolnick,et al.  Faculty Opinions recommendation of Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment. , 2018, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

[26]  Zev J. Gartner,et al.  DoubletFinder: Doublet detection in single-cell RNA sequencing data using artificial nearest neighbors , 2018, bioRxiv.

[27]  J. Delisle,et al.  TGF-β in T Cell Biology: Implications for Cancer Immunotherapy , 2018, Cancers.

[28]  Longlong Chen,et al.  MASAN: a novel staging system for prognosis of patients with oesophageal squamous cell carcinoma , 2018, British Journal of Cancer.

[29]  T. Schumacher,et al.  T Cell Dysfunction in Cancer. , 2018, Cancer cell.

[30]  Luke Zappia,et al.  Clustering trees: a visualization for evaluating clusterings at multiple resolutions , 2018, bioRxiv.

[31]  Y. Ba,et al.  Recombinant humanized anti-PD-1 monoclonal antibody (JS001) as salvage treatment for advanced esophageal squamous cell carcinoma: Preliminary results of an open-label, multi-cohort, phase Ib/II clinical study. , 2018 .

[32]  Charlotte Soneson,et al.  Bias, robustness and scalability in single-cell differential expression analysis , 2018, Nature Methods.

[33]  Leland McInnes,et al.  UMAP: Uniform Manifold Approximation and Projection for Dimension Reduction , 2018, ArXiv.

[34]  C. Abnet,et al.  Epidemiology of Esophageal Squamous Cell Carcinoma. , 2017, Gastroenterology.

[35]  Ming-Rong Wang,et al.  Genomic and Epigenomic Aberrations in Esophageal Squamous Cell Carcinoma and Implications for Patients. , 2017, Gastroenterology.

[36]  Hanmei Xu,et al.  Tumor-related interleukins: old validated targets for new anti-cancer drug development , 2017, Molecular Cancer.

[37]  C. Henke,et al.  MicroRNA-101 attenuates pulmonary fibrosis by inhibiting fibroblast proliferation and activation , 2017, The Journal of Biological Chemistry.

[38]  J. Aerts,et al.  SCENIC: Single-cell regulatory network inference and clustering , 2017, Nature Methods.

[39]  Weidong Wei,et al.  Elevated expression of CST1 promotes breast cancer progression and predicts a poor prognosis , 2017, Journal of Molecular Medicine.

[40]  Y. Xuan,et al.  Twist1 is highly expressed in cancer-associated fibroblasts of esophageal squamous cell carcinoma with a prognostic significance , 2017, Oncotarget.

[41]  Y. Doki,et al.  Nivolumab treatment for oesophageal squamous-cell carcinoma: an open-label, multicentre, phase 2 trial. , 2017, The Lancet. Oncology.

[42]  Hans Clevers,et al.  Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer , 2017, The Journal of experimental medicine.

[43]  Y. Park,et al.  Cystatin SN inhibits auranofin-induced cell death by autophagic induction and ROS regulation via glutathione reductase activity in colorectal cancer , 2017, Cell Death & Disease.

[44]  P. Schnepp,et al.  Tumor-induced Stromal STAT1 Accelerates Breast Cancer via Deregulating Tissue Homeostasis , 2017, Molecular Cancer Research.

[45]  Z. Bago-Horvath,et al.  Colon cancer cell-derived 12(S)-HETE induces the retraction of cancer-associated fibroblast via MLC2, RHO/ROCK and Ca2+ signalling , 2016, Cellular and Molecular Life Sciences.

[46]  Z. Bago-Horvath,et al.  Colon cancer cell-derived 12(S)-HETE induces the retraction of cancer-associated fibroblast via MLC2, RHO/ROCK and Ca2+ signalling , 2016, Cellular and Molecular Life Sciences.

[47]  John J Miles,et al.  Molecular Pathways: Targeting CD96 and TIGIT for Cancer Immunotherapy , 2016, Clinical Cancer Research.

[48]  Xin Xu,et al.  Spatial intratumor heterogeneity of genetic, epigenetic alterations and temporal clonal evolution in esophageal squamous cell carcinoma , 2016, Nature Genetics.

[49]  R. Kalluri.  The biology and function of fibroblasts in cancer , 2016, Nature Reviews Cancer.

[50]  F. Ginhoux,et al.  Expansion and Activation of CD103(+) Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition. , 2016, Immunity.

[51]  Fabian J. Theis,et al.  destiny: diffusion maps for large-scale single-cell data in R , 2015, Bioinform..

[52]  P. Linsley,et al.  MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data , 2015, Genome Biology.

[53]  C. Sung,et al.  Twist1 is a key regulator of cancer-associated fibroblasts. , 2015, Cancer research.

[54]  Amber J. Giles,et al.  Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy , 2014, Science Translational Medicine.

[55]  K. Ohuchida,et al.  Podoplanin expression in cancer-associated fibroblasts enhances tumor progression of invasive ductal carcinoma of the pancreas , 2013, Molecular Cancer.

[56]  J-T Kim,et al.  Cystatin SN neutralizes the inhibitory effect of cystatin C on cathepsin B activity , 2013, Cell Death and Disease.

[57]  Nayoung Kim,et al.  Podoplanin, α-Smooth Muscle Actin or S100A4 Expressing Cancer-Associated Fibroblasts Are Associated with Different Prognosis in Colorectal Cancers , 2013, Journal of Korean medical science.

[58]  Michael C. Ostrowski,et al.  Transcription factor ATF3 links host adaptive response to breast cancer metastasis. , 2013, The Journal of clinical investigation.

[59]  Takeshi Takahashi,et al.  Autocrine and paracrine loops between cancer cells and macrophages promote lymph node metastasis via CCR4/CCL22 in head and neck squamous cell carcinoma , 2013, International journal of cancer.

[60]  M. Zeng,et al.  Overexpression of Cystatin SN positively affects survival of patients with surgically resected esophageal squamous cell carcinoma , 2013, BMC Surgery.

[61]  V. Seshan,et al.  A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis , 2012, Cell.

[62]  G. Evan,et al.  Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology. , 2012, Blood.

[63]  C. Compton,et al.  Esophagus and Esophagogastric Junction , 2012 .

[64]  Eugene H. Blackstone,et al.  7th Edition of the AJCC Cancer Staging Manual: Esophagus and Esophagogastric Junction , 2010, Annals of Surgical Oncology.

[65]  J. Joyce,et al.  IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. , 2010, Genes & development.

[66]  C. Rüegg,et al.  Endothelial cells as key determinants of the tumor microenvironment: interaction with tumor cells, extracellular matrix and immune killer cells. , 2010, Critical reviews in immunology.

[67]  Seon-Young Kim,et al.  Upregulation of the cysteine protease inhibitor, cystatin SN, contributes to cell proliferation and cathepsin inhibition in gastric cancer. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[68]  Thomas Lengauer,et al.  Improved scoring of functional groups from gene expression data by decorrelating GO graph structure , 2006, Bioinform..

[69]  Stéphane Lafon,et al.  Diffusion maps , 2006 .

[70]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[71]  Ann B. Lee,et al.  Geometric diffusions as a tool for harmonic analysis and structure definition of data: diffusion maps. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[72]  D. Woodfield.  Hepatocellular carcinoma. , 1986, The New Zealand medical journal.